Dose-dependent acute liver injury with hypersensitivity features in humans due to a novel microsomal prostaglandin E synthase 1 inhibitor-Reference-Cited by-同舟云学术

Dose-dependent acute liver injury with hypersensitivity features in humans due to a novel microsomal prostaglandin E synthase 1 inhibitor

Published:2017-10-08 Issue:1 Volume:84 Page:179-188
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Jin Yan¹^ORCID,Regev Arie¹,Kam Jeanelle²,Phipps Krista¹,Smith Claire¹,Henck Judith¹,Campanale Kristina¹,Hu Leijun¹,Hall D. Greg¹,Yang Xiao Yan¹,Nakano Masako³,McNearney Terry Ann¹,Uetrecht Jack⁴,Landschulz William¹

Affiliation:

1. Eli Lilly and Company; Indianapolis Indiana USA

2. Covance Clinical Research Unit; Dallas Texas USA

3. Eli Lilly Japan K.K.; Kobe Japan

4. Leslie Dan Faculty of Pharmacy; University of Toronto; Toronto Ontario Canada

Funder

Eli Lilly and Company

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.13423/fullpdf

Reference26 articles.

1. Nonsteroidal anti-inflammatory drugs and hepatic toxicity: a systematic review of randomized controlled trials in arthritis patients;Rostom;Clin Gastroenterol Hepatol,2005

2. Pharmacokinetic-pharmacodynamic correlations and biomarkers in the development of COX-2 inhibitors;Huntjens;Rheumatology (Oxford),2005

3. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis;Warner;Proc Natl Acad Sci U S A,1999

4. Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2;McAdam;Proc Natl Acad Sci U S A,1999

5. Reduced pain hypersensitivity and inflammation in mice lacking microsomal prostaglandin e synthase-1;Kamei;J Biol Chem,2004

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel 1,3,4-oxadiazole derivatives as highly potent microsomal prostaglandin E2 synthase-1 (mPGES-1) inhibitors;Bioorganic Chemistry;2024-06

2. Design and synthesis of new dihydropyrimidine/sulphonamide hybrids as promising anti-inflammatory agents via dual mPGES-1/5-LOX inhibition;Frontiers in Chemistry;2024-05-10

3. Inhibition of Microsomal Prostaglandin E2 Synthase Reduces Collagen Deposition in Melanoma Tumors and May Improve Immunotherapy Efficacy by Reducing T-cell Exhaustion;Cancer Research Communications;2023-07-31

4. Synthesis, in vitro and in silico studies on novel 3-aryloxymethyl-5-[(2-oxo-2-arylethyl)sulfanyl]-1,2,4-triazoles and their oxime derivatives as potent inhibitors of mPGES-1;Journal of Molecular Structure;2023-01

5. Novel potent benzimidazole-based microsomal prostaglandin E2 synthase-1 (mPGES-1) inhibitors derived from BRP-201 that also inhibit leukotriene C4 synthase;European Journal of Medicinal Chemistry;2022-03